Results 281 to 290 of about 89,230 (317)
Portal Hypertension in Children: Investigating Umbilical Catheterization in the Neonatal Period. [PDF]
CureusBouhafs N +4 more
europepmc +1 more source
Molecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinics in Liver Disease, 2019
Portal hypertension (PH) is a clinical syndrome resulting from the combination of increased portal blood flow and increased portal resistance and characterized by an increase in the portosystemic gradient beyond the physiological value of 5 mmHg. PH is a common complication in patients with chronic liver disease, both adults and children, and its major
Di Giorgio A., D'Antiga L.
openaire +3 more sources
Portal hypertension (PH) is a clinical syndrome resulting from the combination of increased portal blood flow and increased portal resistance and characterized by an increase in the portosystemic gradient beyond the physiological value of 5 mmHg. PH is a common complication in patients with chronic liver disease, both adults and children, and its major
Di Giorgio A., D'Antiga L.
openaire +3 more sources
Current Opinion in Gastroenterology, 1997
Significant advances in the pathophysiology, diagnosis and management of the complications of portal hypertension that have occurred in the last year are reported.The specific areas reviewed are those that refer to experimental studies aimed at modifying the factors that lead to portal hypertension (increased intrahepatic vascular resistance and ...
openaire +9 more sources
Significant advances in the pathophysiology, diagnosis and management of the complications of portal hypertension that have occurred in the last year are reported.The specific areas reviewed are those that refer to experimental studies aimed at modifying the factors that lead to portal hypertension (increased intrahepatic vascular resistance and ...
openaire +9 more sources
Clinics in Liver Disease, 2001
Many advances in the management of portal hypertension and variceal hemorrhage have occurred during the last 10 years. Effective therapy for primary prevention of variceal hemorrhage is now available in the form of nonselective beta-blockers. Active bleeding should be managed with terlipressin, somatostatin or its analogues, and endoscopic therapy ...
N, Garcia, A J, Sanyal
openaire +2 more sources
Many advances in the management of portal hypertension and variceal hemorrhage have occurred during the last 10 years. Effective therapy for primary prevention of variceal hemorrhage is now available in the form of nonselective beta-blockers. Active bleeding should be managed with terlipressin, somatostatin or its analogues, and endoscopic therapy ...
N, Garcia, A J, Sanyal
openaire +2 more sources
Medical Clinics of North America, 1989
Portal hypertension is a frequent syndrome characterized by a chronic increase in portal venous pressure and by the formation of portal-systemic collaterals. Its main consequence is massive bleeding from ruptured esophageal and gastric varices. Bleeding is promoted by increased portal and variceal pressure, and is favored by dilatation of the varices ...
J, Bosch +4 more
openaire +2 more sources
Portal hypertension is a frequent syndrome characterized by a chronic increase in portal venous pressure and by the formation of portal-systemic collaterals. Its main consequence is massive bleeding from ruptured esophageal and gastric varices. Bleeding is promoted by increased portal and variceal pressure, and is favored by dilatation of the varices ...
J, Bosch +4 more
openaire +2 more sources